HOME >> BIOLOGY >> NEWS
New version of tumor-suppressor linked to progression of childhood cancer

Researchers have discovered an unexpected role as a tumor promoter for a molecule that was previously thought to function exclusively as a cancer suppressor in neuroblastoma (NB), a highly aggressive and deadly childhood cancer. The study, published in the October issue of Cancer Cell, reveals new evidence about what stimulates progression of neuroblastoma and may provide a likely target for new anti-cancer therapies.

Neurotrophin tyrosine kinase receptor type I (TrkA) responds to nerve growth factor and plays a key role in the development of the nervous system. Mutated TrkA has been associated with many human cancers, including colon, thyroid and prostate cancers. However, previous studies have suggested that TrkA acts as a tumor-suppressor in NB. Dr. Andrew R. Mackay and colleagues from the University of L'Aquila in Italy found a previously undiscovered variant of TrkA, called TrkIII, which exhibits oncogenic properties in human NB cells. TrkIII levels are elevated in advanced stage NB tumors, suggesting that the molecule may play a role in cancer progression. The researchers found that the level of TrkIII resulting from altered splicing of TrkA transcripts is controlled in part by hypoxia, a condition where cells are deprived of oxygen that is known to contribute to cancer progression. The researchers found that TrkIII stimulated advancement of NB, in part, by interfering with the normal anti-oncogenic function of TrkA.

The researchers conclude that formation of TrkIII represents a tumor-promoting switch in NB. Preventing generation of TrkIII may serve to inhibit NB progression. "A potential mechanism for regulating NB progression based on alternative TrkAIII splicing rather than genetic TrkA abnormality would theoretically permit reversal by re-establishing regular TrkA (I/II) splicing, which would represent a potential therapeutic goal," explains Dr. Mackay.

Antonella Tacconelli, Antonietta R. Farina, Lucia Cappabianca, Giuseppina DeSant
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
18-Oct-2004


Page: 1 2

Related biology news :

1. Scientific American launches innovative new version of magazine
2. Researchers pit novel version of common virus against cancer
3. Land conversion and climate threaten land birds
4. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
5. Solar energy conversion offers a solution to help mitigate global warming
6. Gene sequencing advance will aid in biomass-to-biofuels conversion
7. Common gene version optimizes thinking -- but with a possible downside
8. Software, evolution and micro-inversions -- improving the building of phylogenetic trees
9. New hominid species may be early version of Homo sapiens
10. Berkeley researchers lay groundwork for cell version of DNA chip
11. DOE JGI releases fourth version of IMG in 2005

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... (PRWEB) , ... February 12, 2019 , ... Ava, a ... old, she partially tore one of her cruciate ligaments. Just one year later, ... by nature, was able to recover without surgical intervention and resumed her normal activities ...
(Date:2/11/2019)... ... February 11, 2019 , ... Bode Technology (Bode), ... forensic genealogy service offering to law enforcement investigators and crime laboratories. ... develop ancestral relationships between samples and deliver leads to our clients. , For ...
(Date:2/6/2019)... ... February 04, 2019 , ... ... Explorerâ„¢ story which provides insights to help individuals understand how the gut microbes ... wellness. , After individuals eat foods that contain choline and L-carnitine, such ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... January 23, 2019 , ... Through its ... research support in study design, planning, sample collection, and analysis to researchers at ... Campus in Trinidad led by Dr. Elaine Monica Davis, MBBS, MPhil, Lecturer of ...
(Date:1/20/2019)... Milwaukee (PRWEB) , ... January 17, 2019 , ... The ... release of its Patient Education program , a new initiative for 2019. Designed ... is designed to educate and inform patients, families, and the public on the status ...
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... With the U.S. Congress designating January as ... transmitted disease (STD) testing service, today announces tips to help reduce the risk of Cervical ... Human Papillomavirus (HPV). Genital HPV is the #1 most common STD and an ...
(Date:1/10/2019)... ... January 08, 2019 , ... ... innovative spinal implant company, announced today that SAGICO will be represented at ... The annual J.P. Morgan Healthcare Conference is the largest and most informative ...
Breaking Biology Technology:
Cached News: